ENTITY
GSK

GSK (GSK LN)

143
Analysis
Health Care • United Kingdom
GSK is a British multinational biopharmaceutical company focused on the research, development, and delivery of innovative vaccines and specialty medicines. It addresses major disease areas including HIV, respiratory, oncology, and infectious diseases. The company was established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, and is headquartered in London, England.
more
•24 Jun 2016 16:11

Will Brexit Break EM's Back?

Against market expectations the British have voted to exit the European Union, a process that could take a few years.Ā The first order impact is...

Logo
353 Views
Share
•12 Jun 2016 13:50

Dragon Capital's VEIL Fund: A 3rd London Listing for Vietnam May Emerge Next Month

Transition from the Irish Stock Exchange to the London Stock ExchangeDragon Capital’s fundĀ Vietnam Enterprise Investments Limited, which currently...

Logo
1.2k Views
Share
•10 Jun 2016 16:42

Generation Hashtag as an Investment Theme

Forget everything you learned about Millennials....Millennials were ā€˜digital’ as defined by the discrete electronic tasks they performed on...

Logo
335 Views
Share
•26 May 2016 21:55

Internet of Things in Agriculture

A few months ago, I wrote a piece titled "Investing in the Internet of Things" and I made a case for the bright future of IoT and its myriad...

Logo
586 Views
Share
•08 Apr 2026 08:30

Hansoh Pharmaceutical (3692 HK): Innovative Drugs and BD Momentum Drive 2025 Performance

​Hansoh beats expectations with 27% YoY net profit growth to RMB6B in 2025, on 23% YoY revenue growth to RMB15B. Innovative medicines revenue...

Logo
143 Views
Share
x